Sponsored Links
| Relypsa Announces Presentation Of Positive Phase 2 Results For RLY5016 At American Society Of Hypertension Meeting |
 |
 |
 |
| Medical News - Hypertension | |||
|
Relypsa, Inc. today announced the presentation of positive results from a Phase 2 clinical trial of the company's lead compound, RLY5016, a non-absorbed oral potassium binder being developed as a treatment for hyperkalemia (elevated serum potassium levels)... Read more: Hypertension News From Medical News Today
|